Cabot (CBT) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $1.67
- Estimate
- $1.66
- Surprise
- +0.7%
- Score at report (before → after)
- 5.9 → 5.9/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Cabot (CBT) beat the $1.66 estimate with diluted EPS of $1.67 — a modest 0.7% upside surprise. TrendMatrix's engine moved from Buy (Wait) (5.9/10) to Hold at 5.9/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates CBT Hold at 5.8/10.
4 of the last 4 quarters beat the estimate; this quarter's +0.7% surprise compares with a +5.7% four-quarter average. Next scheduled report: 2026-11-02.
What supports the rating
- Strong earnings beat streak (4/4)
- Attractive valuation
What argues against it
- Analyst target reached - limited upside remaining
- Negative momentum
- Target reached (-1.5% upside)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $80.65
- Price target
- $86.96
- Stop
- $77.76
- Upside to target
- +7.8%
The stock trades at 23.4× trailing but 11.8× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 29 — a level conventionally read as oversold.
Model outputs from TrendMatrix’s engine as of 2026-09-02 — shown for context, not personalized investment advice.
CBT at TrendMatrix's latest read
Materials producers report against the commodity cycle — realized-price capture and volume, not the EPS line, are the tells in a quarter like this.
- Industry
- Specialty Chemicals
- Market cap
- $4.27B
- P/E (fwd)
- 11.8
- P/E (ttm)
- 23.4
- 52-week range
- $58.33–$94.53
- Off 52-week high
- 14.7%
- RSI (14)
- 29
- Volume vs avg
- 0.91×
- Score today
- 5.8/10